Bookmark

Add to MyYahoo RSS

J and J Snack Foods News

News on J and J Snack Foods (Ticker: JJSF) continually updated from thousands of sources around the net.

4 hrs ago | Courier News

Heartbeats: Public campaign underway for Saint Peter'sHeartbeats:...

Heartbeats: Public campaign underway for Saint Peter's Health news from New Brunswick, Bernards, Branchburg, Woodbridge, Central Jersey Check out this story on mycentraljersey.com: http://mycj.co/1mydYkp The new and expanded Pediatric Emergency Department at Saint Peter's University Hospital in New Brunswick was completed in the spring of 2013 and ... (more)

Comment?

Related Topix: Medicine, Saint Peter's University Hospital, Hospital Administration, Healthcare Industry, New Brunswick, NJ, Women's Health, Health, Johnson & Johnson, Food

7 hrs ago | MSN Money

J&J buying back $5 billion worth of its shares

Johnson & Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

10 hrs ago | GuruFocus.com

Two Food Companies That Can Deliver Long-Term Growth

The packaged food industry in the U.S. is experiencing a solid boom, mainly because of the lack of time people have due to a busy lifestyle and rising commodity prices.

Comment?

Related Topix: Food, ConAgra Foods, Agriculture, Rah

Fri Jul 18, 2014

The Motley Fool

3 Crucial Questions Johnson & Johnson Needs to Answer

But with any company as big as J&J, not every investor question can be answered, and sometimes the leftover question marks are pretty big.

Comment?

Related Topix: Food

Thu Jul 17, 2014

Adweek

Johnson's Baby Latches on to Royal Toddler's Birthday to Build Social Strategy

New moms sometimes go overboard with taking and sharing photos of their kids on social media.

Comment?

Related Topix: Family, Kids, Food, Marketing, Startups, Facebook, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Wed Jul 16, 2014

JD Supra

Mergers and Acquisitions Under the FCPA, Part III

Today I conclude my three-part series on mergers and acquisitions under the Foreign Corrupt Practices Act with a review of the post-acquisition phase.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

The China Post

JandJ 2Q profit climbs 13% on new drug sales

Strong sales of several new drugs, particularly its hot new hepatitis medicine, lifted Johnson & Johnson's second-quarter profit by 13 percent, topping analysts' expectations.

Comment?

Related Topix: Food

Refrigerated & Frozen Foods

New Twist to Old Favorites

A new twist to pretzels J&J Snack Foods Corp., Pennsauken, N.J., introduced a new twist to its S UPERPRETZEL brand.

Comment?

Related Topix: Food, Pennsauken, NJ, Life, Seafood, Baked Goods, Bread, Bar-B-Q

The Motley Fool

A Surprising Johnson & Johnson Stock Growth Driver, Revealed

But it wasn't just Olysio that drove growth. This 'sleepy' business segment turned in 6% worldwide growth at constant currency .

Comment?

Related Topix: Food

Freshnews

Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D....

EPIRUS Biopharmaceuticals, Inc. , a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced that Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. will serve on its board of directors.

Comment?

Related Topix: Biotech, CombinatoRx, Medicine, Healthcare Industry, Sport Movies, Drama Movies, Comedy Movies, College, Sepracor, Cubist Pharmaceuticals, Food

Tue Jul 15, 2014

Medical Device/Diagnostic Ind.

What Does Johnson & Johnson's CEO Think of the Medtronic-Covidien Merger?

In Johnson & Johnson's second quarter 2014 earnings call today, one analyst asked chairman and CEO Alex Gorsky for his take on Gorsky's response, in essence, was that J&J saw something like this coming a mile away and beat its competitors to the punch.

Comment?

Related Topix: Food

HAPPI/Household & PP Industry

Q2 Sales Rise at J&J

Johnson & Johnson posted a 9.1% increase in sales of $19.5 billion for the second quarter of 2014.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Reuters

UPDATE 3-J&J beats forecasts, helped by new hepatitis C drug

Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.

Comment?

Related Topix: Food, Hepatitis, Medicine, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics

Seeking Alpha

Stocks point to higher open after J.P. Morgan, Goldman post Q2 beats

Stock futures are modestly higher after a batch of generally positive economic reports and better than expected earnings results from JPMorgan Chase and Goldman Sachs; S&P +0.1% , Dow and Nasdaq +0.2% .

Comment?

Related Topix: Goldman Sachs, Financial Services, Investment Services, Banking, JP Morgan Chase , Financial Markets, Food

Sunherald.com

J&J 2Q profit climbs 13 percent on new-drug sales

The results topped analysts' expectations. The maker of Band-Aids, medical devices and biologic drugs raised its 2014 profit forecast for the second time this year, again up by a nickel to a new range of $5.85 to $5.92 per share.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Globe and Mail

J&J profit rises 13% to $4.3-billion, beats forecast

Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. The diversified healthcare company on Tuesday said it had earned $4.33-billion, or $1.51 per share, in the second quarter.

Comment?

Related Topix: Food, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

WTHR-TV Indianapolis

J&J 2Q profit climbs 13 percent on new-drug sales

When a woman's pickup stalled on a street in Santa Fe, New Mexico, local chef Jackson Ault stopped to lend a hand.

Comment?

Related Topix: Food, Santa Fe, NM, Bill Haslam, US Governors, Life, Veteran Affairs

MarketWatch

Movers & Shakers: Goldman Sachs, Johnson & Johnson report earnings Tuesday

Goldman Sachs Group Inc. : The financial services giant is expected to report a profit of $3.07 per share on revenue of $7.98 billion, according to a consensus of analysts surveyed by FactSet.

Comment?

Related Topix: Goldman Sachs, Financial Services, Investment Services, Food

Mon Jul 14, 2014

Beyond Madison Ave

AdLand Strikes Back: Bot Wars

Bots. When data came out less than a year ago that a large amount of web clicks and online traffic is due to bots, and not people, the advertising community was furious.

Comment?

Related Topix: Marketing, Food

The Motley Fool

Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth?

Despite Johnson & Johnson having a wide array of health-care-related businesses spanning medical devices and consumer over-the-counter products, the company has emphasized the growth potential of its pharmaceutical unit.

Comment?

Related Topix: Tylenol, Tempra, Acetaminophen (generic), Medicine, Food, Diabetes

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••